These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Thyrotoxic myopathy: research status, diagnosis, and treatment. Cui H; Zhang X Endokrynol Pol; 2022; 73(1):157-162. PubMed ID: 35119093 [TBL] [Abstract][Full Text] [Related]
27. [Thyrotoxic hypokalemic periodic paralysis: a rare complication of a common disease]. Foppiani L; Cuttica CM; Marugo A; Del Monte P Recenti Prog Med; 2012 Sep; 103(9):333-6. PubMed ID: 23023021 [TBL] [Abstract][Full Text] [Related]
28. [A case of thyrotoxic myopathy with generalized body muscular atrophy including the tongue muscle, lacking physical manifestations of Basedow disease]. Kitahara S; Tonouchi T; Otsu Y; Kawachi I; Oyake M; Fujita N Rinsho Shinkeigaku; 2020 Oct; 60(10):677-681. PubMed ID: 32893239 [TBL] [Abstract][Full Text] [Related]
29. Response to control of hyperthyroidism in patients with myasthenia gravis and thyrotoxicosis. Teoh R; Chow CC; Kay R; Cockram CS; McGuire L Br J Clin Pract; 1990 Dec; 44(12):742-4. PubMed ID: 2102222 [TBL] [Abstract][Full Text] [Related]
31. Congenital myasthenic syndrome due to mutation in CHRNE gene with clinical worsening and thymic hyperplasia attributed to association with autoimmune-myasthenia gravis. Santos E; Moreira I; Coutinho E; Gonçalves G; Lopes C; Lopes Lima J; Leite MI Neuromuscul Disord; 2015 Dec; 25(12):928-31. PubMed ID: 26363966 [TBL] [Abstract][Full Text] [Related]
32. A Periodic Problem. Kratka A; Yozamp N; Vaidya A; Marqusee E N Engl J Med; 2021 Jul; 385(5):e17. PubMed ID: 34320291 [No Abstract] [Full Text] [Related]
33. Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs. Suzuki S; Ichikawa K; Nagai M; Mikoshiba M; Mori J; Kaneko A; Sekine R; Asanuma N; Hara M; Nishii Y; Yamauchi K; Aizawa T; Hashizume K Arch Intern Med; 1997 Mar; 157(6):693-6. PubMed ID: 9080924 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic imaging and therapy in a case of myasthenia gravis associated with thymic hyperplasia. Foschi R; Rinaldi P; Meduri A; Campioni P; Pirronti T Rays; 2003; 28(4):369-78. PubMed ID: 15152539 [TBL] [Abstract][Full Text] [Related]
35. Hyperthyroidism presenting with hyperglycemia in an adolescent female. Wintergerst KA; Rogers ES; Foster MB J Pediatr Endocrinol Metab; 2011; 24(5-6):385-7. PubMed ID: 21823542 [TBL] [Abstract][Full Text] [Related]
36. Thymic hyperplasia in Graves' disease. Van Herle AJ; Chopra IJ J Clin Endocrinol Metab; 1971 Feb; 32(2):140-6. PubMed ID: 4099281 [No Abstract] [Full Text] [Related]
37. Thyrotoxic hypokalemic periodic paralysis in a Turkish male with graves' disease: a rare case report and review of the literature. Erem C Endocrine; 2005 Jun; 27(1):63-5. PubMed ID: 16077173 [TBL] [Abstract][Full Text] [Related]
39. Thymic hyperplasia in patients with Graves' disease. Dalla Costa M; Mangano FA; Betterle C J Endocrinol Invest; 2014 Dec; 37(12):1175-9. PubMed ID: 25149085 [TBL] [Abstract][Full Text] [Related]
40. Thymic hyperplasia and its spontaneous resolution with treatment of Graves' hyperthyroidism. Shanmugasundaram M; Varadhan L; Katreddy MV; Nayak AU BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27190120 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]